Heritage Trust Co bought a new stake in shares of MetLife, Inc. (NYSE:MET - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 33,857 shares of the financial services provider's stock, valued at approximately $2,772,000.
Several other hedge funds also recently modified their holdings of MET. Retirement Wealth Solutions LLC acquired a new stake in MetLife during the 4th quarter worth $32,000. Sierra Ocean LLC acquired a new position in MetLife in the fourth quarter valued at about $32,000. Graney & King LLC bought a new position in MetLife during the fourth quarter worth about $34,000. Values First Advisors Inc. acquired a new position in shares of MetLife during the 4th quarter worth about $36,000. Finally, Golden State Wealth Management LLC bought a new stake in shares of MetLife in the 4th quarter valued at about $44,000. Institutional investors own 94.99% of the company's stock.
Wall Street Analysts Forecast Growth
MET has been the subject of a number of analyst reports. StockNews.com cut shares of MetLife from a "buy" rating to a "hold" rating in a report on Thursday, January 9th. Morgan Stanley decreased their price target on shares of MetLife from $109.00 to $94.00 and set an "overweight" rating for the company in a report on Thursday, April 10th. JPMorgan Chase & Co. dropped their price objective on MetLife from $88.00 to $86.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 2nd. Wells Fargo & Company decreased their target price on MetLife from $97.00 to $91.00 and set an "overweight" rating for the company in a research note on Thursday, April 10th. Finally, Cowen reaffirmed a "buy" rating on shares of MetLife in a research report on Friday, March 7th. Two investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company's stock. According to MarketBeat.com, MetLife presently has a consensus rating of "Moderate Buy" and an average price target of $92.46.
Read Our Latest Stock Report on MET
MetLife Stock Down 0.7 %
Shares of MET stock traded down $0.52 during trading on Wednesday, reaching $72.19. The company's stock had a trading volume of 1,090,268 shares, compared to its average volume of 3,392,269. MetLife, Inc. has a one year low of $65.21 and a one year high of $89.05. The business has a fifty day moving average price of $79.86 and a 200-day moving average price of $82.33. The company has a market cap of $49.18 billion, a price-to-earnings ratio of 12.09, a price-to-earnings-growth ratio of 0.65 and a beta of 0.89. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.54.
MetLife (NYSE:MET - Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $2.08 EPS for the quarter, missing analysts' consensus estimates of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. Analysts anticipate that MetLife, Inc. will post 9.65 earnings per share for the current year.
About MetLife
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Read More

Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.